Omeros Corporation
About
Omeros Corporation (NASDAQ:OMER) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
Apr 16 2026
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
Mar 31 2026
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
Mar 26 2026
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
Mar 21 2026
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
Financials
Revenue
-$30 M
Market Cap
$772.81 M
EPS
-0.08